Shineco

Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. It operates through the following segments: Luobuma Products, Herbal Products, and Other Agricultural Products. The Luobuma Products segment focuses in the development, manufacture, and distribution of specialized fabrics, textile products, and other by-products derived from an indigenous Chinese plant called Apocynum Venetum. The Herbal Products segment involves in the processing and distribution of traditional Chinese medicinal herbal products as well as other pharmaceutical products. The Other Agricultural Products segment comprises planting, processing, and distribution of green and organic agricultural produce and growing and cultivating of Chinese Yew trees. The company was founded on August 20, 1997 and is headquartered in Beijing, China.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BEIJING, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products and other biotech products, announced that its ticker symbol on the Nasdaq Stock Market (NASDAQ) will change to "SISI" at the open of market trading on Monday, October 18, 2021. Shineco has traded under the ticker "TYHT" since the Company's initial public offering in 2016.

Shineco, Inc. Announces Nasdaq Ticker Symbol Change from "TYHT" to "SISI"

BEIJING, June 01, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced in response to unusual market activity, and after speaking with its officers, directors, major shareholders and other relevant persons, that it is unaware of the reason behind recent stock price volatility. The Company confirms that there is no corporate development relating to its business and affairs that has not been previously announced.

Shineco, Inc. Announces It's Unaware of Reason for Stock Volatility

BeiGene

Galmed Pharmaceuticals

Novavax

Sinovac Biotech

The WHO approved Sinopharm's COVID-19 vaccine for emergency use, which will give poorer nations access to a vaccine against the global pandemic. CoronaVac is the first China-developed COVID-19 vaccine under consideration in Europe, joining vaccines from CureVac, Novavax and a Russian vaccine, Sputnik V.

Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines

BEIJING, May 07, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced that Mr. Guocong Zhou had step down as CEO of the Company, effective May 5, 2021. He was succeeded by Ms. Ou Yang, who has extensive experience in the capital market and the healthcare industry, on May 6, 2021.

Shineco, Inc. Announces Appointment of New CEO

The stock price of Shineco Inc (NASDAQ: TYHT) increased from $11.94 to $16.23 (up 35.93%) today. This is why it happened.

TYHT Stock: From $11.94 To $16.23 (35.93% Increase) Explanation

BEIJING, May 04, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced the Company and Mayah Biological Holdings Limited (“Mayah Biological”), a British Virgin Islands Company headquartered in Taiwan Biomedical Park, had signed a Proposal for Purchase of Equity Interest of Mayah Biological Holding Limited (the “Proposal”), with respect to the potential purchase of at least 51% equity interests in Mayah Biological by the Company.

Shineco, Inc. Proposes to Acquire 51% Equity Interests in Mayah Biological Holdings Limited

BEIJING, Sept.  28, 2020  (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, as well as various health and well-being-focused plant-based products in China, announced today its financial results for the fiscal year ended June 30, 2020.

Shineco, Inc. Reports Fiscal Year 2020 Financial Results

BEIJING, Aug.  13, 2020  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, as well as various health and well-being-focused plant-based products in China, announced today that the Company's common stock will trade on a split-adjusted basis following the implementation of a reverse stock split at the ratio of one-for-nine shares on The Nasdaq Capital Market (“Nasdaq”) effective with the open of the market on Monday, August 17, 2020.

Shineco Announces One-for-Nine Reverse Stock Split Effective August 17, 2020

Dr. Fengming Liu to Become New CEO and Chief Scientist

Shineco, Inc. Announces CEO Change for Strategic Transformation

BEIJING, July  27, 2020  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, as well as various health and well-being-focused plant-based products in China, announced today that the Company has entered into a non-binding letter of intent (the “Letter of Intent”) to acquire controlling interest in Changzhou Biowin Pharmaceutical Co., Ltd (“CBP”), a Chinese biotechnology company focusing on on-site diagnostic product R & D and high-tech biomedical products manufacturing, to step into the market of COVID-19 nucleic acid detection.

Shineco, Inc. Enters into a Letter of Intent to Acquire Controlling Interest in Changzhou Biowin Pharmaceutical Co.

BEIJING, Jan.  24, 2020  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd. (“SCHT”), has entered into a strategic cooperation agreement (the “Agreement”) with Pacific Islands Trade and Investment Commission (“PITIC”) to explore business opportunities of Industrial Hemp in Pacific Island areas.

Shineco, Inc. Enters into Strategic Cooperation Agreement with Pacific Islands Trade & Investment Commission

BEIJING, Dec.  27, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that the Company received a letter from Nasdaq Listing Qualifications Staff (“Nasdaq”) that the Company has been granted an additional 180-day grace period or until June 20, 2020 (“Expiration Date”) to regain compliance with the minimum $1.00 bid price per share Listing Rule (the “Rule”).

Shineco, Inc. Receives Extension of Compliance Period from Nasdaq

BEIJING, Dec.  23, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today the Company, through its wholly owned subsidiary Beijing Tenjove NewHemp Biotech Co., Ltd. ("TNB"), has entered into a strategic cooperation agreement (the “Agreement”) with Wuchang Municipal Government of Heilongjiang Province (the “Government”) on December 18, 2019.

Shineco, Inc. Enters into Strategic Cooperation Agreement with Wuchang Municipal Government of Heilongjiang Province

BEIJING, Dec.  16, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that Mr. Yuying Zhang, Chairman and Chief Executive Officer of Shineco, has reached a consensus on cooperation with Vice Mayor Zhang Jianchun of Wuchang municipal government of Heilongjiang Province (the Government) regarding Shineco’s industry hemp development plan in Heilongjiang Province (the “Plan”).

Shineco, Inc. Reaches Consensus on Cooperation with Wuchang Municipal Government of Heilongjiang Province

BEIJING, Dec.  12, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd. (“SCHT”), has award an certificate (the “Certificate”) from Trade & Association (Singapore) (“TIAS”) on November 29, 2019 to jointly establish industry hemp comprehensive utilization park (the “Park”) in China. The Certificate is effective for 3 years.

Shineco, Inc. Awarded Certificate from Trade & Association (Singapore) to Jointly Establish Industry Hemp Comprehensive Utilization Park in China

BEIJING, Dec.  09, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that its wholly owned subsidiary Tenjove NewHemp Biotech Co., Ltd. ("TNB") has achieved progress in its industrial product system which focuses on cannabidiol development (“CBD”). The Company has achieved good progress with hemp planting, product research and development, and technical supports.

Shineco, Inc. Announces Progress with CBD Product System Construction

BEIJING, Dec.  06, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that it completed its first board meeting (the "Meeting") for fiscal year 2019 held on November 26, 2019 in Beijing, China and pursuant to which the Company’s directors:

Shineco, Inc. Announces the Completion of its First Board Meeting for Fiscal Year 2019

BEIJING, Dec.  05, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that it has regained compliance with Nasdaq’s continued listing requirement and rules with respect to annual meeting of shareholders.

Shineco, Inc. Regains Compliance with Nasdaq Continued Listing Requirement and Rules with Respect to Annual Meeting of Shareholders

BEIJING, Dec.  04, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd.(“SCHT”), has entered into a 500,000 mu (approximately 82,348 acres) hemp fiber preliminary processing sales framework contract (the “Contract”) with Shanxi Oasis Textile Co., Ltd.(“Oasis”), one of the largest enterprises in China that produces textiles of hemp [and is the National Textile Industry Hemp Product Development Base.

Shineco, Inc. Enters into Hemp Fiber Preliminary Processing Sales Framework Contract with Shanxi Oasis Textile Co.

Dolphin Entertainment

Enservco

Coffee Holding

Smart Sand

I'll tell you whether you should buy or stay away from these penny stocks. Remember, even the so-called best penny stocks are volatile!

Five Penny Stocks to Buy If You Can Risk It

Shineco Inc. announced a partnership with Heilongjiang Zhenye Agricultural Technology Development Co. Thursday to build the largest planting and processing base for industrial hemp in China and potentially acquire Zhenye Agricultural. 

News for Shineco Stock (TYHT)